2-(1,3-benzodioxol-5-yl)-7-(4-chlorophenyl)imidazo[1,2-a]pyrazin-8(7H)-one structure
|
Common Name | 2-(1,3-benzodioxol-5-yl)-7-(4-chlorophenyl)imidazo[1,2-a]pyrazin-8(7H)-one | ||
|---|---|---|---|---|
| CAS Number | 1113106-38-9 | Molecular Weight | 398.8 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H19ClN4O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 2-(1,3-benzodioxol-5-yl)-7-(4-chlorophenyl)imidazo[1,2-a]pyrazin-8(7H)-one |
|---|
| Molecular Formula | C20H19ClN4O3 |
|---|---|
| Molecular Weight | 398.8 |
| InChIKey | LDGCZVXEXNOOMU-UHFFFAOYSA-N |
| SMILES | O=C(Cn1cc(-c2nc(-c3ccc(Cl)cc3)no2)ccc1=O)NC1CCCC1 |
|
Name: High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id: HMS1303
|